0 items USD 0.00Search
Your search for "gbi research endpoints clinical trials orphan diseases highest number terminated trials focused" gave back 139 results.
Alzheimer’s disease is the most common cause of dementia among older people. It is a devastating condition for those afflicted as well as their...
iGATE
July 2017
Price: USD 1,250.00
Achillion Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report Summary Achillion Pharmaceuticals, Inc. - Strategy, SWOT and Corporate...
MarketLine
February 2020
Price: USD 175.00
Cassava Sciences Inc - Strategy, SWOT and Corporate Finance Report Summary Cassava Sciences Inc - Strategy, SWOT and Corporate Finance Report, is a...
MarketLine
January 2023
Price: USD 175.00
The University of Texas MD Anderson Cancer Center - Strategy, SWOT and Corporate Finance Report Summary The University of Texas MD Anderson Cancer...
MarketLine
November 2022
Price: USD 175.00
Alcami Corporation - Strategy, SWOT and Corporate Finance Report Summary Alcami Corporation - Strategy, SWOT and Corporate Finance Report, is a...
MarketLine
November 2022
Price: USD 175.00
Apotex, Inc. - Strategy, SWOT and Corporate Finance Report Summary Apotex, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of...
MarketLine
November 2022
Price: USD 175.00
Danaher Corporation - Strategy, SWOT and Corporate Finance Report Summary Danaher Corporation - Strategy, SWOT and Corporate Finance Report, is a...
MarketLine
November 2022
Price: USD 175.00
PAREXEL International Corporation - Strategy, SWOT and Corporate Finance Report Summary PAREXEL International Corporation - Strategy, SWOT and...
MarketLine
November 2022
Price: USD 175.00
Quest Diagnostics Incorporated - Strategy, SWOT and Corporate Finance Report Summary Quest Diagnostics Incorporated - Strategy, SWOT and Corporate...
MarketLine
January 2023
Price: USD 175.00
Celldex Therapeutics, Inc. - Strategy, SWOT and Corporate Finance Report Summary Celldex Therapeutics, Inc. - Strategy, SWOT and Corporate Finance...
MarketLine
December 2022
Price: USD 175.00
Sunesis Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report Summary Sunesis Pharmaceuticals, Inc. - Strategy, SWOT and Corporate...
MarketLine
November 2020
Price: USD 175.00
Rigel Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report Summary Rigel Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance...
MarketLine
December 2022
Price: USD 175.00
Laboratory Corporation of America Holdings - Strategy, SWOT and Corporate Finance Report Summary Laboratory Corporation of America Holdings -...
MarketLine
December 2022
Price: USD 175.00
The global market for High intensity focused ultrasound (HIFU) is increasing rapidly primarily driven by the increase in cancer patient’s population...
iGATE
June 2017
Price: USD 1,150.00
Ultragenyx Pharmaceutical Inc. - Strategy, SWOT and Corporate Finance Report Summary Ultragenyx Pharmaceutical Inc. - Strategy, SWOT and Corporate...
MarketLine
January 2023
Price: USD 175.00
